TITLE

Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study

AUTHOR(S)
Piche, T.; Vanbiervliet, G.; Cherikh, F.; Antoun, Z.; Huet, P. M.; Gelsi, E.; Demorquay, J.-F.; Caroli-Bosc, F.-X.; Benzaken, S.; Rigoult, M.-C.; Renou, C.; Rampal, P.; Tran, A.
PUB. DATE
August 2005
SOURCE
Gut;Aug2005, Vol. 54 Issue 8, p1169
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: There are no available effective therapies for fatigue associated with chronic hepatitis C (CHC). The serotonin antagonist ondansetron has been shown to be effective in the chronic fatigue syndrome. In this randomised, placebo controlled, double blind trial, we investigated the effect of orally administered ondansetron on fatigue in CHC. Methods: Thirty six patients with CHC were included if fatigue was their predominant symptom and they scored more than 4 on a visual analogue scale (0-10). During the study, fatigue and depression were measured on days 0, 15, 30, and 60 using a validated self report questionnaire (fatigue impact scale and Beck depression inventory). Patients were randomised to receive ondansetron tablets 4 mg twice daily or placebo for one month followed by an additional four weeks of observation. Results: Fatigue score was 85.4 (28.2) and 98.2 (26.9) in the ondansetron and placebo groups, respectively (NS). Ondansetron significantly reduced the fatigue score with more than 30% improvement on day 15 (57.1 (38.9); p<0.01), day 30 (54.5 (37.6); p<0.01), and day 60 (60.8 (37.3); p<0.0l) whereas placebo did not. Overall, the reduction in fatigue was significantly higher with ondansetron compared with placebo (ANOVA for repeated measurements) for the whole follow up period (p =0.03) or for the treatment period only (p =0.04). Ondansetron also significantly reduced depression scores. conclusions: The 5-hydroxytryptamine receptor type 3 antagonist ondansetron had a significant positive effect on fatigue in CHC. These observations support the concept that fatigue involves serotoninergic pathways and may encourage further evaluations of the efficacy of ondansetron on fatigue in chronic liver diseases.
ACCESSION #
17814016

 

Related Articles

  • Hepatitis C Infection Is Associated with Depressive Symptoms in HIV-Infected Adults with Alcohol Problems. Libman, Howard; Saitz, Richard; Nunes, David; Cheng, Debbie M.; Richardson, Jessica M.; Vidaver, John; Alperen, Julie K.; Samet, Jeffrey H. // American Journal of Gastroenterology;Aug2006, Vol. 101 Issue 8, p1804 

    OBJECTIVES: Depression is common in persons with HIV infection and with alcohol problems, and it has important prognostic implications. Neurocognitive dysfunction has been reported with chronic hepatitis C virus (HCV) infection. We hypothesized that HCV infection is associated with more...

  • The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis. Isgro, Graziella; Calvaruso, Vincenza; Andreana, Lorenzo; Luong, Tu; Garcovich, Matteo; Manousou, Pinelopi; Alibrandi, Angela; Maimone, Sergio; Marelli, Laura; Davies, Neil; Patch, David; Dhillon, Amar; Burroughs, Andrew // Journal of Gastroenterology;Aug2013, Vol. 48 Issue 8, p921 

    Background: Collagen proportionate area (CPA) has a better correlation with hepatic venous pressure gradient (HVPG) than with Ishak stage. Liver stiffness measurement (LSM) is proposed as non invasive marker of portal hypertension/disease progression. Our aim was to compare LSM and CPA with...

  • The New Killer Virus You Can Catch From Sex. Califano, Julia // Cosmopolitan;May99, Vol. 226 Issue 5, p236 

    Provides information on hepatitis C. Information on the disease's symptoms; Advice on preventing the disease.

  • Hepatitis C. Bergeron, Emily // Popular Science;Oct2002, Vol. 261 Issue 4, p119 

    Presents facts related to hepatitis C. Definition; Discovery of the disease; Prevalence of the disease; Symptoms.

  • Correction.  // MMWR: Morbidity & Mortality Weekly Report;11/2/2012, Vol. 61 Issue 43, p886 

    A correction is presented to the article "Recommendations for the Identification of Chronic Hepatitis C Infection Among Persons Born During 1945-1965," published in "MMWR: Morbidity & Mortality Weekly Report."

  • Citalopram for the Prevention of Depression and Its Consequences in HIV-Hepatitis C Coinfected Individuals Initiating Pegylated Interferon/Ribavirin Therapy: A Multicenter Randomized Double-Blind Placebo-Controlled Trial. Klein, Marina B.; Lee, Terry; Brouillette, Marie-Josée; Sheehan, Nancy L.; Walmsley, Sharon; Wong, David K.; Conway, Brian; Hull, Mark; Cooper, Curtis; Haidar, Shariq; Vezina, Sylvie; Annable, Lawrence; Young, Simon; Zubyk, Wendy; Singer, Joel // HIV Clinical Trials (Thomas Land Publishers Incorporated);Jul/Aug2014, Vol. 15 Issue 4, p161 

    Background: Depression related to interferon-alpha (IFN-α) is common, may reduce adherence, and can be treatment limiting. HIV-HCV coinfected persons experience lower sustained virologie response rates and commonly have psychiatric comorbidities, thus they may benefit from prevention of...

  • Summaries for Patients. Prevention of Depression in Patients Treated for Chronic Hepatitis C Virus Infection With Interferon-alpha. Schaefer, M.; Sarkar, R.; Knop, V.; Effenberger, S.; Friebe, A.; Heinze, L.; Spengler, U.; Schlaepfer, T.; Reimer, J.; Buggisch, P.; Ockenga, J.; Link, R.; Rentrop, M.; Weidenbach, H.; Fromm, G.; Lieb, K.; Baumert, T. F.; Heinz, A.; Discher, T.; Neumann, K. // Annals of Internal Medicine;7/17/2012, Vol. 157 Issue 2, pI-40 

    The article presents information on a study on the use of antidepressant drug to prevent depression in patients who are treated for chronic Hepatitis C virus infection with interferon (IFN)-alpha. The antidepressant drug escitalopram or a placebo pill was given to the patients for two weeks...

  • Peginterferon-a-2b: highs and lows in chronic HCV infection.  // Reactions Weekly;10/29/2005, Issue 1075, p4 

    Reports on the occurrence of affective disorders during peginterfeon-α-2b therapy in patients with chronic hepatitis C virus infection according to French researchers. Number of patients involved in the study; Percentage of patients who developed peginterferon-α-2b induced affective...

  • A Preliminary Study on the Relationship between Platelet Serotonin Transporter Functionality, Depression, and Fatigue in Patients with Untreated Chronic Hepatitis C. Franke, Leonora; Therstappen, Eric; Schlosser, Beate; Biermer, Michael; Berg, Thomas; Schäfer, Martin; Arck, Petra; Uebelhack, Ralf; Friebe, Astrid // Depression Research & Treatment;2014, p1 

    Objective and Methods. Although the interaction between fatigue and depression in patients with chronic hepatitis C infection (HCV) has been recognized, the biological correlates of this observation have yet to be reported. We addressed this issue by examining serotonin transporter- (SERT-)...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics